We are live on
!
Find out more
ONC
BeOne Medicines Ltd
222 hedge funds and large institutions have $7.2B invested in BeOne Medicines Ltd in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 73 increasing their positions, 78 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
333% more call options, than puts
Call options by funds: $12.1M | Put options by funds: $2.79M
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
0.02% less ownership
Funds ownership: 3.99% → 3.97% (-0.02%)
6% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 78
5% less funds holding
Funds holding: 234 → 222 (-12)
17% less capital invested
Capital invested by funds: $8.65B → $7.2B (-$1.45B)
28% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 36
Holders
222
Holders Change
-12
Holders Change %
-5.13%
% of All Funds
3.82%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
26
Increased
73
Reduced
78
Closed
36
Calls
$12.1M
Puts
$2.79M
Net Calls
+$9.3M
Net Calls Change
+$2.34M
Top Buyers
| 1 |
Primecap Management
Pasadena,
California
|
+$121M |
| 2 |
Temasek Holdings
Singapore
|
+$24.6M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$22.7M |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$18M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$13.8M |
